Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Etidronic acid.
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Etidronic acid.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etidronic acid.
Advertisement
Aclarubicin
Aclarubicin may increase the hypocalcemic activities of Etidronic acid.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Etidronic acid.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Etidronic acid.
Advertisement
Aluminum
The serum concentration of Etidronic acid can be decreased when it is combined with Aluminium.
Aluminum Hydroxide
The serum concentration of Etidronic acid can be decreased when it is combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The serum concentration of Etidronic acid can be decreased when it is combined with Aluminum hydroxide.
Advertisement
Aluminum Magnesium Silicate
The serum concentration of Etidronic acid can be decreased when it is combined with Almasilate.
Amikacin
Amikacin may increase the hypocalcemic activities of Etidronic acid.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Etidronic acid.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Etidronic acid.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Etidronic acid.
Arbekacin
Arbekacin may increase the hypocalcemic activities of Etidronic acid.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Etidronic acid.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Etidronic acid.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Etidronic acid.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Etidronic acid.
Bismuth Subcitrate
The serum concentration of Etidronic acid can be decreased when it is combined with Bismuth Subcitrate.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Etidronic acid.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Etidronic acid.
Calcium Acetate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Acetate.
Calcium Carbonate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Carbonate.
Calcium Chloride
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Chloride.
Calcium Chloride Anhydrous
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Chloride.
Calcium Citrate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Citrate.
Calcium Glubionate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium glubionate.
Calcium gluceptate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Gluceptate.
Calcium Gluconate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium gluconate.
Calcium Lactate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium lactate.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Etidronic acid.
Casein Allergenic Extract
The serum concentration of Etidronic acid can be decreased when it is combined with Casein.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Etidronic acid.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Etidronic acid.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Etidronic acid.
Clofezone
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Rabeprazole.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Etidronic acid.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Etidronic acid.
Daunorubicin
Daunorubicin may increase the hypocalcemic activities of Etidronic acid.
Deferasirox
The risk or severity of adverse effects can be increased when Etidronic acid is combined with Deferasirox.
Dexlansoprazole
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Dexlansoprazole.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Etidronic acid.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Etidronic acid.
Dihydrostreptomycin
Dihydrostreptomycin may increase the hypocalcemic activities of Etidronic acid.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Etidronic acid.
Doxorubicin
Doxorubicin may increase the hypocalcemic activities of Etidronic acid.
Doxorubicin Hydrochloride
Doxorubicin may increase the hypocalcemic activities of Etidronic acid.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Etidronic acid.
Epirubicin
Epirubicin may increase the hypocalcemic activities of Etidronic acid.
Esomeprazole
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Esomeprazole.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Etidronic acid.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Etidronic acid.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Etidronic acid.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Etidronic acid.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Etidronic acid.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Etidronic acid.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Etidronic acid.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Etidronic acid.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Etidronic acid.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Etidronic acid.
Framycetin
Framycetin may increase the hypocalcemic activities of Etidronic acid.
Gentamicin
Gentamicin may increase the hypocalcemic activities of Etidronic acid.
Hydrotalcite
The serum concentration of Etidronic acid can be decreased when it is combined with Hydrotalcite.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Etidronic acid.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Etidronic acid.
Idarubicin
Idarubicin may increase the hypocalcemic activities of Etidronic acid.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Etidronic acid.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Etidronic acid.
Iron Sucrose
The serum concentration of Etidronic acid can be decreased when it is combined with Iron saccharate.
Kanamycin
Kanamycin may increase the hypocalcemic activities of Etidronic acid.
kanamycin A
Kanamycin may increase the hypocalcemic activities of Etidronic acid.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Etidronic acid.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Etidronic acid.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Etidronic acid.
Lansoprazole
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Lansoprazole.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Etidronic acid.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Etidronic acid.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Etidronic acid.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Etidronic acid.
Magnesium Hydroxide
The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium hydroxide.
Magnesium Oxide
The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium oxide.
Magnesium Salicylate
The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium salicylate.
Magnesium Sulfate
The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium sulfate.
Magnesium Trisilicate
The serum concentration of Etidronic acid can be decreased when it is combined with Magnesium Trisilicate.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Etidronic acid.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Etidronic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Etidronic acid.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Etidronic acid.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Etidronic acid.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Etidronic acid.
Metrizamide
Metrizamide may increase the hypocalcemic activities of Etidronic acid.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Etidronic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Etidronic acid.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Etidronic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Etidronic acid.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Etidronic acid.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Etidronic acid.
Neomycin
Neomycin may increase the hypocalcemic activities of Etidronic acid.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Etidronic acid.
Netilmicin
Netilmicin may increase the hypocalcemic activities of Etidronic acid.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Etidronic acid.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Etidronic acid.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Etidronic acid.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Etidronic acid.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Etidronic acid.
Omeprazole
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Omeprazole.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Etidronic acid.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Etidronic acid.
Pantoprazole
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Pantoprazole.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Etidronic acid.
Paromomycin
Paromomycin may increase the hypocalcemic activities of Etidronic acid.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Etidronic acid.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Etidronic acid.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etidronic acid.
Pirarubicin
Pirarubicin may increase the hypocalcemic activities of Etidronic acid.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Etidronic acid.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Etidronic acid.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Etidronic acid.
Plicamycin
Plicamycin may increase the hypocalcemic activities of Etidronic acid.
Rabeprazole
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Rabeprazole.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Etidronic acid.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Etidronic acid.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Etidronic acid.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Etidronic acid.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Etidronic acid.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Etidronic acid.
Sisomicin
Sisomicin may increase the hypocalcemic activities of Etidronic acid.
Spectinomycin
Spectinomycin may increase the hypocalcemic activities of Etidronic acid.
Streptomycin
Streptomycin may increase the hypocalcemic activities of Etidronic acid.
Streptozocin
Streptozocin may increase the hypocalcemic activities of Etidronic acid.
Sucroferric Oxyhydroxide
The serum concentration of Etidronic acid can be decreased when it is combined with Iron saccharate.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Etidronic acid.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Etidronic acid.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Etidronic acid.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Etidronic acid.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Etidronic acid.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Etidronic acid.
Tobramycin
Tobramycin may increase the hypocalcemic activities of Etidronic acid.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Etidronic acid.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Etidronic acid.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Etidronic acid.
Tricalcium Phosphate
The serum concentration of Etidronic acid can be decreased when it is combined with Calcium Phosphate.
Tromethamine
The serum concentration of Etidronic acid can be decreased when it is combined with Tromethamine.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Etidronic acid.
Valrubicin
Valrubicin may increase the hypocalcemic activities of Etidronic acid.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Etidronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Etidronic acid.
